Pharmaceutical compositions directed to Erb-B1 receptors

Details for Australian Patent Application No. 2003273964 (hide)

Owner Merck Patent GmbH

Inventors Kreysch, Hans-Georg; Schmidt, Jurgen

Agent Davies Collison Cave

Pub. Number AU-B-2003273964

PCT Number PCT/EP03/11164

PCT Pub. Number WO2004/032960

Priority 02022389.7 10.10.02 EP; 02022390.5 10.10.02 EP

Filing date 9 October 2003

Wipo publication date 4 May 2004

Acceptance publication date 19 November 2009

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/32 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

12 February 2004 Complete Application Filed

  Priority application(s): 02022389.7 10.10.02 EP; 02022390.5 10.10.02 EP

3 June 2004 Application Open to Public Inspection

  Published as AU-B-2003273964

19 November 2009 Application Accepted

  Published as AU-B-2003273964

18 March 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003273965-PROCESS FOR MAKING BICALUTAMIDE AND INTERMEDIATES THEREOF

2003273963-NOISE PREVENTION WALL SYSTEM COMPRISING A BASE AND A TRANSPARENT TOP PART